These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 16129533)

  • 1. Humans appear no more sensitive than laboratory animals to the inhibition of red blood cell cholinesterase by dichlorvos.
    MacGregor JA; Plunkett LM; Youngren SH; Manley A; Plunkett JB; Starr TB
    Regul Toxicol Pharmacol; 2005 Nov; 43(2):150-67. PubMed ID: 16129533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulating and assessing risks of cholinesterase-inhibiting pesticides: divergent approaches and interpretations.
    Carlock LL; Chen WL; Gordon EB; Killeen JC; Manley A; Meyer LS; Mullin LS; Pendino KJ; Percy A; Sargent DE; Seaman LR; Svanborg NK; Stanton RH; Tellone CI; Van Goethem DL
    J Toxicol Environ Health B Crit Rev; 1999; 2(2):105-60. PubMed ID: 10230391
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human red blood cell acetylcholinesterase inhibition as the appropriate and conservative surrogate endpoint for establishing chlorpyrifos reference dose.
    Chen WL; Sheets JJ; Nolan RJ; Mattsson JL
    Regul Toxicol Pharmacol; 1999 Feb; 29(1):15-22. PubMed ID: 10051415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weak inhibitors protect cholinesterases from stronger inhibitors (dichlorvos): in vitro effect of tiapride.
    Petroianu GA; Schmitt A; Arafat K; Hasan MY
    Int J Toxicol; 2005; 24(2):79-86. PubMed ID: 16036766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo effects of dichlorvos on blood cholinesterase activities of cattle.
    Khan AA; Coppock RW; Schuler MM; Lillie LE
    Am J Vet Res; 1988 Jul; 49(7):1184-7. PubMed ID: 3421541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of benchmark dose and meta-analysis to determine the most sensitive endpoint for risk assessment for dimethoate.
    Reiss R; Gaylor D
    Regul Toxicol Pharmacol; 2005 Oct; 43(1):55-65. PubMed ID: 16099569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transdermal patch delivery of acetylcholinesterase inhibitors.
    Moriearty PL; Thornton SL; Becker RE
    Methods Find Exp Clin Pharmacol; 1993; 15(6):407-12. PubMed ID: 8231460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiotoxic effects of dichlorvos (DDVP) in albino rats.
    Naidu KA; Viswanatha S; Krishnakumari MK
    Indian J Physiol Pharmacol; 1987; 31(1):19-24. PubMed ID: 3666870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of pyridostigmine bromide and huperzine A protects human whole blood cholinesterases from ex vivo exposure to soman.
    Gordon RK; Haigh JR; Garcia GE; Feaster SR; Riel MA; Lenz DE; Aisen PS; Doctor BP
    Chem Biol Interact; 2005 Dec; 157-158():239-46. PubMed ID: 16256090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of dichlorvos on blood cholinesterase activities of cattle.
    Khan AA; Coppock RW; Schuler MM; Lillie LE
    Am J Vet Res; 1990 Jan; 51(1):79-82. PubMed ID: 2301824
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of neferine on toxicodynamics of dichlorvos for inhibiting rabbit cholinesterase.
    Xiong YQ; Zeng FD
    Acta Pharmacol Sin; 2003 Apr; 24(4):332-6. PubMed ID: 12676073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic analysis of the toxic effects of chronic exposure to low-level dichlorvos on rats using ultra-performance liquid chromatography-mass spectrometry.
    Yang J; Sun X; Feng Z; Hao D; Wang M; Zhao X; Sun C
    Toxicol Lett; 2011 Oct; 206(3):306-13. PubMed ID: 21889581
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of metrifonate, its transformation product dichlorvos, and other organophosphorus and reference cholinesterase inhibitors on Morris water escape behavior in young-adult rats.
    van der Staay FJ; Hinz VC; Schmidt BH
    J Pharmacol Exp Ther; 1996 Aug; 278(2):697-708. PubMed ID: 8768721
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of the reference dose for chlorpyrifos.
    Zhao Q; Dourson M; Gadagbui B
    Regul Toxicol Pharmacol; 2006 Mar; 44(2):111-24. PubMed ID: 16360256
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterizing interspecies uncertainty using data from studies of anti-neoplastic agents in animals and humans.
    Price PS; Keenan RE; Swartout JC
    Toxicol Appl Pharmacol; 2008 Nov; 233(1):64-70. PubMed ID: 18514247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deriving a data-based interspecies assessment factor using the NOAEL and the benchmark dose approach.
    Bokkers BG; Slob W
    Crit Rev Toxicol; 2007 Jun; 37(5):355-73. PubMed ID: 17612951
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weak inhibitors protect cholinesterases from strong inhibitors (paraoxon): in vitro effect of tiapride.
    Petroianu GA; Hasan MY; Arafat K; Nurulain SM; Schmitt A
    J Appl Toxicol; 2005; 25(6):562-7. PubMed ID: 16193528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and pharmacodynamics of metrifonate in humans.
    Unni LK; Womack C; Hannant ME; Becker RE
    Methods Find Exp Clin Pharmacol; 1994 May; 16(4):285-9. PubMed ID: 8051989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retina, brain and blood cholinesterase levels in cats treated with oral dichlorvos.
    Harlin KS; Dellinger JA
    Vet Hum Toxicol; 1993 Jun; 35(3):201-3. PubMed ID: 8351788
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.